“The Asia-Pacific amino acids, peptides & proteins market is estimated to grow at a CAGR of 6.5% during the forecast period of 2014 to 2019. The Asia-Pacific consumers are increasingly becoming aware about their health and nutrition. This is mainly due to the changing lifestyles of the growing middle class population. The rise in the purchasing power of this middle-income population enables them to spend on nutraceutical products, which cater to the problems related to their dynamic lifestyles.
In this report, the Asia-Pacific amino acids, peptides & proteins market has been brodlly discussed by its applications such as functional food, functional beverages, dietary supplement, animal nutrition, and personal care. The dietary supplement market is estimated to grow at the fastest CAGR during the given forecast period. The awareness regarding amino acids, peptides & proteins ingredients in the supplementary food and personal care segments is a major diving force for the growth of the Asia-Pacific amino acids, peptides & proteins market.
Japan is the largest market for amino acids, peptides & proteins in Asia-Pacific, having accounted for a share of 32.1% in 2014, followed by China. The market in India is projected to grow at the fastest CAGR during the given forecast period. The constituents of the Asia-Pacific region lack regulations related to nutraceuticals products. The health claims related to particular products lack validation from concerned governmental authorities. Every government has its own clinical approval agency that has its own norms and regulations. The nutraceutical ingredient manufacturers face several difficulties while developing products that will adhere to these norms completely.
Cargill Inc. (U.S.) holds a major share of the Asia-Pacific amino acids, peptides & proteins market as of 2014. Archer Daniels Midland Co. held a share of 5.8% in the same year. Ajinomoto (Japan), Kerry Ingredients (Ireland), and Royal DSM (Netherlands) are competing for a major share in the rapidly-growing amino acids, peptides & proteins market in the Asia-Pacific region. These companies are engaged in market strategies such as mergers & acquisitions, joint ventures, new product developments, and expansions to increase their market share in the Asia-Pacific amino acids, peptides & proteins market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis, market share analysis of top players, company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the Asia-Pacific amino acids, peptides & proteins market; high-growth countries and their respective regulatory policies; government initiatives; and market drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater share of the concerned market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on amino acids, peptides & proteins offered by the top 10 players in the Asia-Pacific amino acids, peptides & proteins market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Asia-Pacific amino acids, peptides & proteins market
• Market Development: Comprehensive information about lucrative emerging markets; the report analyzes the markets for various applications of amino acids, peptides & proteins across Asia-Pacific
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Asia-Pacific amino acids, peptides & proteins market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Asia-Pacific amino acids, peptides & proteins m
”
“TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET SEGMENTATION & COVERAGE 12
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 INTEGRATED ECOSYSTEM OF AMINO ACIDS, PEPTIDES &
PROTEINS (NUTRACEUTICAL) MARKET 14
2.2 ARRIVING AT THE AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL)
MARKET SIZE 15
2.2.1 TOP-DOWN APPROACH 16
2.2.2 DEMAND-SIDE APPROACH 18
2.2.3 MACRO INDICATOR-BASED APPROACH 19
2.3 ASSUMPTIONS 20
3 EXECUTIVE SUMMARY 22
4 MARKET OVERVIEW 23
4.1 INTRODUCTION 23
4.2 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPARISON WITH PARENT MARKET 25
4.3 MARKET DRIVERS & INHIBITORS 26
4.4 KEY MARKET DYNAMICS 27
4.5 DEMAND-SIDE ANALYSIS 30
5 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET, BY APPLICATION 31
5.1 INTRODUCTION 32
5.2 DEMAND-SIDE ANALYSIS 35
5.3 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL FOODS, BY COUNTRY 38
5.4 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL BEVERAGES, BY COUNTRY 40
5.5 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN DIETARY SUPPLEMENTS, BY COUNTRY 42
5.6 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN ANIMAL FEED, BY COUNTRY 44
5.7 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN PERSONAL CARE,
BY COUNTRY 46
5.8 SNEAK VIEW: ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET, BY APPLICATION, 2014 (USD MN) 48
6 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET, BY COUNTRY 49
6.1 INTRODUCTION 50
6.2 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET 52
6.2.1 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION 53
6.3 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET 55
6.3.1 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION 56
6.4 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET 58
6.4.1 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION 59
6.5 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET 61
6.5.1 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION 62
7 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPETITIVE LANDSCAPE 64
7.1 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPANY SHARE ANALYSIS 64
7.2 MERGERS & ACQUISITIONS 65
7.3 EXPANSIONS 66
7.4 INVESTMENTS 67
7.5 JOINT VENTURES 68
8 COMPANY PROFILES 69
8.1 ARCHER DANIELS MIDLAND COMPANY 69
8.1.1 OVERVIEW 69
8.1.2 KEY OPERATIONS DATA 70
8.1.3 KEY FINANCIALS 70
8.1.4 PRODUCT OFFERINGS 70
8.1.5 RELATED DEVELOPMENTS 71
8.1.6 MMM VIEW 71
8.2 CARGILL, INCORPORATED 72
8.2.1 OVERVIEW 72
8.2.2 KEY FINANCIALS 73
8.2.3 PRODUCT OFFERINGS 73
8.2.4 RELATED DEVELOPMENTS 73
8.2.5 MMM VIEW 74
8.3 KERRY GROUP PLC 75
8.3.1 OVERVIEW 75
8.3.2 KEY FINANCIALS 75
8.3.3 PRODUCT OFFERINGS 76
8.3.4 RELATED DEVELOPMENTS 76
8.3.5 MMM VIEW 76
8.4 AJINOMOTO CO., INC. 77
8.4.1 OVERVIEW 77
8.4.2 KEY FINANCIALS DATA 78
8.4.3 PRODUCT OFFERINGS 78
8.4.4 RELATED DEVELOPMENTS 79
8.4.5 MMM VIEW 79
8.5 ROYAL DSM N.V. 80
8.5.1 OVERVIEW 80
8.5.2 KEY FINANCIALS 81
8.5.4 RELATED DEVELOPMENTS 83
8.5.5 MMM VIEW 83
9 APPENDIX 84
9.1 CUSTOMIZATION OPTIONS 84
9.1.1 TRENDS ANALYSIS 84
9.1.2 REGULATORY FRAMEWORKS 84
9.1.3 TECHNICAL ANALYSIS 84
9.1.4 COMPETITIVE ADVANTAGE 84
9.2 RELATED REPORTS 85
9.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 86
9.3.1 RT SNAPSHOTS 87
“
“LIST OF TABLES
UU
TABLE 1 GLOBAL AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) PEER MARKET SIZE, 2014 (USD MN) 17
TABLE 2 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2014 (USD MILLION) 19
TABLE 3 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (ABSOLUTE POPULATION) 20
TABLE 4 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (USD MN) 25
TABLE 5 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2019 (TONS) 25
TABLE 6 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: DRIVERS & INHIBITORS 26
TABLE 7 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 27
TABLE 8 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 28
TABLE 9 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY COUNTRY, 2013 – 2019 (USD MN) 28
TABLE 10 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY GEOGRAPHY, 2013 – 2019 (TONS) 29
TABLE 11 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPARISON WITH APPLICATION MARKETS, 2013 – 2019 (USD MN) 30
TABLE 12 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 33
TABLE 13 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 34
TABLE 14 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL FOODS, BY COUNTRY, 2013 – 2019 (USD MN) 38
TABLE 15 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL FOODS, BY COUNTRY, 2013 – 2019 (TONS) 39
TABLE 16 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL BEVERAGES, BY COUNTRY, 2013 – 2019 (USD MN) 40
TABLE 17 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN FUNCTIONAL BEVERAGES, BY COUNTRY, 2013 – 2019 (TONS) 41
TABLE 18 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN DIETARY SUPPLEMENTS, BY COUNTRY, 2013 – 2019 (USD MN) 42
TABLE 19 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN DIETARY SUPPLEMENTS, BY COUNTRY, 2013 – 2019 (TONS) 43
TABLE 20 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN ANIMAL FEED, BY COUNTRY, 2013 – 2019 (USD MN) 44
TABLE 21 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN ANIMAL FEED, BY COUNTRY, 2013 – 2019 (TONS) 45
TABLE 22 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN PERSONAL CARE, BY COUNTRY, 2013 – 2019 (USD MN) 46
TABLE 23 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) IN PERSONAL CARE, BY COUNTRY, 2013 – 2019 (TONS) 47
TABLE 24 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2014 (USD MN) 48
TABLE 25 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY COUNTRY, 2013 – 2019 (USD MN) 50
TABLE 26 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY COUNTRY, 2013 – 2019 (TONS) 51
TABLE 27 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 53
TABLE 28 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 54
TABLE 29 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 56
TABLE 30 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 57
TABLE 31 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 59
TABLE 32 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 60
TABLE 33 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 62
TABLE 34 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (TONS) 63
TABLE 35 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 64
TABLE 36 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: MERGERS & ACQUISITIONS 65
TABLE 37 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: EXPANSIONS 66
TABLE 38 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: INVESTMENTS 67
TABLE 39 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET:
JOINT VENTURES 68
TABLE 40 ARCHER DANIELS MIDLAND COMPANY: KEY FINANCIAL DATA, 2009 – 2013 (USD MN) 70
TABLE 41 ARCHER DANIELS MIDLAND COMPANY: KEY FINANCIALS, 2009 – 2013 (USD MN) 70
TABLE 43 KERRY GROUP PLC: KEY FINANCIALS, 2009 – 2013 (USD MN) 75
TABLE 45 AJINOMOTO CO., INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 78
TABLE 46 AJINOMOTO CO., INC.: KEY OPERATIONS DATA, 2010 – 2014 (USD MN) 78
TABLE 47 ROYAL DSM N.V.: KEY FINANCIALS, 2009 – 2013 (USD MN) 81
TABLE 48 ROYAL DSM N.V.: KEY OPERATIONS DATA, 2009 – 2013 (USD MN) 81
“
“LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: SEGMENTATION & COVERAGE 12
FIGURE 2 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: INTEGRATED ECOSYSTEM 14
FIGURE 3 RESEARCH METHODOLOGY 15
FIGURE 4 TOP-DOWN APPROACH 16
FIGURE 5 DEMAND-SIDE APPROACH 18
FIGURE 6 MACRO INDICATOR-BASED APPROACH 19
FIGURE 7 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET SNAPSHOT, 2014 22
FIGURE 8 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: GROWTH ASPECTS 24
FIGURE 9 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2014 VS. 2019 27
FIGURE 10 DEMAND-SIDE ANALYSIS 30
FIGURE 11 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL): APPLICATION MARKET SCENARIO 32
FIGURE 12 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2014 VS. 2019 (USD MN) 33
FIGURE 13 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2014 VS. 2019 (TONS) 34
FIGURE 14 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET IN FUNCTIONAL FOOD, BY COUNTRY, 2013 – 2019 (USD MN) 38
FIGURE 15 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET IN FUNCTIONAL BEVERAGES, BY COUNTRY, 2013 – 2019 (USD MN) 40
FIGURE 16 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET IN DIETARY SUPPLEMENTS, BY COUNTRY, 2013 – 2019 (USD MN) 42
FIGURE 17 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET IN ANIMAL FEED, BY COUNTRY, 2013 – 2019 (USD MN) 44
FIGURE 18 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET IN PERSONAL CARE, BY COUNTRY, 2013 – 2019 (USD MN) 46
FIGURE 19 SNEAK VIEW: ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET, BY APPLICATION, 2014 (USD MN) 48
FIGURE 20 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: GROWTH ANALYSIS, BY COUNTRY, 2014 – 2019 (USD MN) 50
FIGURE 21 ASIA-PACIFIC AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: GROWTH ANALYSIS, BY COUNTRY, 2014 – 2019 (TONS) 51
FIGURE 22 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET OVERVIEW, 2014 & 2019 (%) 52
FIGURE 23 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 53
FIGURE 24 CHINA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: APPLICATION SNAPSHOT 54
FIGURE 25 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET OVERVIEW, 2014 & 2019 (USD MN) 55
FIGURE 26 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 56
FIGURE 27 INDIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: APPLICATION SNAPSHOT 57
FIGURE 28 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET OVERVIEW, 2014 & 2019 (USD MN) 58
FIGURE 29 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 59
FIGURE 30 JAPAN AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: APPLICATION SNAPSHOT 60
FIGURE 31 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET OVERVIEW, 2014 & 2019 (USD MN) 61
FIGURE 32 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET,
BY APPLICATION, 2013 – 2019 (USD MN) 62
FIGURE 33 AUSTRALIA AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: APPLICATION SNAPSHOT 63
FIGURE 34 AMINO ACIDS, PEPTIDES & PROTEINS (NUTRACEUTICAL) MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 64
FIGURE 35 ARCHER DANIELS MIDLAND COMPANY: REVENUE MIX, 2013 (%) 69
FIGURE 36 CARGILL, INCORPORATED REVENUE MIX, 2013 (%) 72
FIGURE 37 KERRY GROUP PLC: REVENUE MIX, 2014 (%) 75
FIGURE 38 AJINOMOTO CO., INC.: REVENUE MIX 2013 (%) 77
FIGURE 39 ROYAL DSM N.V.: REVENUE MIX, 2014 (%) 80
“
